Trade

with

Alliqua Inc
(NASDAQ: ALQA)
AdChoices
4.39
-0.03
-0.70%
After Hours :
-
-
-

Open

4.46

Previous Close

4.42

Volume (Avg)

27.83k (22.64k)

Day's Range

4.30-4.46

52Wk Range

0.0682-10.11

Market Cap.

71.08M

Dividend Rate ( Yield )

-

Beta

1.28

Shares Outstanding

16.19M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 1.80M

    • Net Income

    • -21.98M

    • Market Cap.

    • 71.08M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1,287.50

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.28

    • Forward P/E

    • -

    • Price/Sales

    • 19.05

    • Price/Book Value

    • 2.42

    • Price/Cash flow

    • -4.79

      • EBITDA

      • -21.29M

      • Return on Capital %

      • -127.52

      • Return on Equity %

      • -153.72

      • Return on Assets %

      • -127.52

      • Book Value/Share

      • 1.82

      • Shares Outstanding

      • 16.19M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -0.80

        • Cashflow Estimate

        • -0.56

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 107.90

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -3.86

            • 69.92

            • Pre-Tax Margin

            • -1,268.88

            • 21.84

            • Net Profit Margin

            • -1,287.50

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.32

              • Current Ratio

              • 6.70

              • 1.92

              • Quick Ratio

              • 6.43

              • 1.31

              • Interest Coverage

              • -13,202.65

              • 17.64

              • Leverage Ratio

              • 1.23

              • 2.03

              • Book Value/Share

              • 1.82

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.40

                • 21.74

                • P/E Ratio 5-Year High

                • -4.86

                • 193.96

                • P/E Ratio 5-Year Low

                • -0.44

                • 87.26

                • Price/Sales Ratio

                • 17.99

                • 3.68

                • Price/Book Value

                • 2.29

                • 3.66

                • Price/Cash Flow Ratio

                • -4.79

                • 13.76

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -153.72

                    (-83.20)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • -127.52

                    (-75.10)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • -153.71

                    (-83.10)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • -

                  • 90.07k

                  • Inventory Turnover

                  • 3.93

                  • 2.46

                  • Asset Turnover

                  • 0.10

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -20.13M
                  Operating Margin
                  -1,119.87
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -4.79
                  Ownership

                  Institutional Ownership

                  23.65%

                  Top 10 Institutions

                  28.18%

                  Mutual Fund Ownership

                  1.11%

                  Float

                  76.83%

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    134,898

                  • 0.00

                  • 0.83

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    31,587

                  • 0.00

                  • 0.20

                  • Vanguard Extended Market Index Fund

                  •  

                    8,880

                  • 0.00

                  • 0.05

                  • Fidelity® NASDAQ Composite Index® Fund

                  •  

                    2,954

                  • 0.00

                  • 0.02

                  • AXA/Lord Abbett Micro Cap Portfolio

                  •  

                    1,899

                  • 0.00

                  • 0.01

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Celgene Corp

                  •  

                    2,386,760

                  • +42.71%

                  • 19.04

                  • J. Goldman & Co LP

                  •  

                    720,687

                  • +41.31%

                  • 4.45

                  • Suffolk Capital Management LLC

                  •  

                    259,295

                  • +39.19%

                  • 1.60

                  • Vanguard Group, Inc.

                  •  

                    123,234

                  • +0.49%

                  • 0.76

                  • Millennium Management LLC

                  •  

                    100,000

                  • 0.00%

                  • 0.62

                  • American European Insurance Company

                  •  

                    83,247

                  • +32.48%

                  • 0.72

                  • JHL Capital Group LLC

                  •  

                    65,000

                  • -18.75%

                  • 0.40

                  • Geode Capital Management, LLC

                  •  

                    34,541

                  • +182.80%

                  • 0.21

                  • Zeke Capital Advisors, LLC

                  •  

                    20,820

                  • +31.61%

                  • 0.13

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Speculative Growth

                  Style

                  Small Core

                  Alliqua, Inc., a Florida corporation formed on October 21, 1997. It is a biomedical company through its subsidiary providing advanced wound care solutions. The Company’s core business includes; advanced wound care and contract manufa...morecturing. The Company develops, manufactures and markets high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its subsidiary manufactures and markets its hydrogel products. Its products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. Together, these technologies enable it to produce gels that can satisfy rigid toleranc...moree specifications with respect to a range of physical characteristics (e.g., thickness, water content, adherence, absorption, moisture vapor transmission rate (a measure of the passage of water vapor through a substance) and release rate) while maintaining product integrity. In July 2012, it began to market two proprietary products, SilverSeal®, a hydrogel wound dressing with silver coated fibers, and Hydress®, an over-the-counter hydrogel wound dressing. It supplies these gels mainly to the wound care segment of the healthcare industry. The Company’s SilverSeal and Hydress dressings are each currently available in two sizes and are used to provide and maintain a moist wound environment. SilverSeal dressings also provide an antimicrobial barrier. On November 14, 2013 Company entered into a license, marketing and development agreement with Anthrogenesis Corporation, Celgene Cellular Therapeutics (“CCT”), an affiliate of Celgene Corporation, pursuant to which CCT granted an exclusive, royalty-bearing license in its intellectual property related to certain placental based products, including the wound care products Extracellular Matrix (“ECM”), a suite of advanced wound management products made from extracellular matrix derived from the human placenta and Biovance®, a collagen-based decellularized and dehydrated topical wound covering produced from human amniotic membrane for the management of non-infected partial- and full-thickness wounds; and also into a supply agreement with CCT, pursuant to which CCT will supply Company with the entire requirement of Biovance for distribution and sale in the United States. The Company’s medical devices are subject to the U.S. Food and Drug Administration’s general controls, which include compliance with the applicable portions of the U.S. Food and Drug Administration’s Quality System Regulation, facility registration and product listing, reporting of adverse medical events, and appropriate, truthful and non-misleading labeling, advertising, and promotional materials. It is subject to various laws and governmental regulations concerning environmental matters and employee safety and health in the U.S. and other countries.lessless

                  Key People

                  David I Johnson

                  CEO/Chairman of the Board, Subsidiary/Director/President

                  Dr. Jerome Bernard Zeldis,M.D.,PhD

                  Chairman of the Board/Director

                  Brian M. Posner

                  CFO

                  Joseph M. Leone

                  Director

                  Jeffrey Sklar

                  Director

                  • Alliqua Inc

                  • 2150 Cabot Boulevard West

                  • Langhorne, PA 19047

                  • USA.Map

                  • Phone: +1 215 702-8550

                  • Fax: -

                  • alliqua.com

                  Incorporated

                  1997

                  Employees

                  39

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: